The Leadership Team

A Chicago-area physicians group, Radiation Oncology Consultants, Limited (ROCL), Central DuPage Hospital, and ProCure Treatment Centers, Inc. announced on July 9, 2007, that they will collaborate to make proton therapy treatment available to patients in need.

ProCure Treatment Centers will manage the construction, operation and maintenance plan for the $140 million, 58,000-square-foot facility that will have the capacity to accommodate up to 1,500 patients per year. The company anticipates the development of the treatment center will create approximately 100 full-time jobs and 400 temporary positions for construction and start-up operations. Illinois-based contractors will be used to construct the facility. All financing for the project is in place and it will be funded entirely through private sources.

ROCL physicians chose to work with ProCure following an exhaustive five-year search to identify and evaluate the best way to provide their patients access to proton therapy. ROCL and ProCure, in turn, selected Central DuPage Hospital, a nationally recognized institution.

About Central DuPage Hospital
Central DuPage Hospital is a nationally recognized 313-bed facility located in Winfield, Ill., a suburb west of Chicago. CDH is a leading center for surgical innovations and was one of the first institutions in the nation to offer robotic-assisted surgery, minimally invasive spine surgery with bio-engineered bone protein and was the first Level III Neonatal Intensive Care Unit in DuPage County. Recently, CDH was recently recognized for the second consecutive year by U.S. News & World Report on the list of Best Hospitals in the orthopaedics category.

The hospital is part of an interdependent network of health-care organizations and services, including convenient care centers, occupational health services and a full range of options for senior living, home health and hospice care. For more information, visit www.cdh.org.

About Radiation Oncology Consultants, Limited
Radiation Oncology Consultants Limited (ROCL), with headquarters in Park Ridge, Ill., is the largest private practice radiation oncology physician group in Illinois.

The practice, composed of 13 board certified radiation oncology physicians who provide cancer care to patients at multiple locations, has been an early adopter of leading technologies used in the treatment of cancer. These technologies include: 3-dimensional conformal radiation therapy (3DCRT), intensity modulated radiation therapy (IMRT), Gamma Knife radiosurgery, Tomotherapy, prostate seed implants, high dose rate brachytherapy (HDR), and, soon, proton therapy.  For more information, visit www.chicagocancer.com.

About ProCure Treatment Centers, Inc.
ProCure Treatment Centers, Inc., based in Bloomington, Ind., was founded in 2005. ProCure partners with leading radiation oncology practices and hospitals and provides management leadership and a comprehensive approach for the design, construction, financing, staffing, training and day-to-day operations of world-class proton therapy centers. ProCure’s solution reduces the time, cost and effort necessary to create a facility. This allows physicians to continue focusing on patient care and increased access to patients who can benefit from this advanced cancer treatment. ProCure’s Training and Development Center is the first facility in the world dedicated to proton therapy.

For more information, visit www.ProCure.com.